Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
SSM Popul Health ; 16: 100935, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34646932

ABSTRACT

BACKGROUND: The use of mobile health has increased worldwide, but along with its increased utilization comes the risk of the digital divide, inequity in access to information and communications technologies, exerting greater influence on health inequity caused by socioeconomic determinants of health. There is a growing need to investigate whether the digitization of existing health interventions has a risk of worsening the health gap. METHODS: We investigated the attitudes of mothers and pregnant women toward digitization of the Maternal and Child Health Handbook (MCHH), a popular personal health record (PHR) used by almost every pregnant woman or mother in Japan, using a cross-sectional survey. We determined sociodemographic factors associated with favorable opinions toward digitization using a multivariate regression model. We then grouped the participants using partitioning around medoids clustering, a machine-learning approach, to interpret their varying attitudes toward digitization in light of their sociodemographic characteristics as well as their affinity toward the paper MCHH. FINDINGS: Higher income and educational level, older age, and less reliance on the MCHH were significantly associated with favorable opinion toward digitization. Clustering analysis identified four latent clusters. The cluster with the highest socioeconomic status (SES) was the most favorable toward digitization, while two clusters with the lowest SES, one of which relied heavily on the paper MCHH, were less favorable of digitization compared to the high SES cluster. The final cluster was comprised of mothers with the experience of raising multiple children and did not rely heavily on the MCHH. INTERPRETATION: Our study identified a socioeconomic divide in opinions toward digitization of an existing health intervention. A hasty digitization may result in an unbalanced uptake of the digitized health intervention among different social classes.

2.
Ann Clin Biochem ; 55(6): 639-646, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29471686

ABSTRACT

Background To clarify the relationship between glycated haemoglobin and glycated albumin concentrations during pregnancy with neonatal outcomes, a multicentre study was conducted by the Japanese Society of Diabetes and Pregnancy. Methods A total of 136 patients (type 1: n = 47, type 2: n = 89) who enrolled in the study were diagnosed based on the Japanese Diabetes Society diagnostic criteria for diabetes mellitus. Thresholds for glycated haemoglobin and glycated albumin were set at 5.8% and 15.8%, respectively, as the upper limits of the reference interval in pregnant women. Result Random plasma glucose decreased linearly, and reached the reference interval at 40 weeks. Glycated albumin concentrations also decreased in the same manner. But glycated haemoglobin concentrations were out of the reference interval during the study. The frequency of the neonatal complications did not show significant differences between the glycated haemoglobin ⩾5.8% group and the glycated haemoglobin <5.8% group. On the other hand, the frequency of neonatal complications showed higher tendency of neonatal complications in the incidence of polycythaemia ( P = 0.094) and heavy-for-date ( P = 0.071) in the glycated albumin ⩾15.8% group compared with the glycated albumin <15.8 group. The respiratory disorder in type 1 diabetes was significantly higher than type 2 diabetes. Conclusions For the treatment of pregnant women with diabetes, glycated albumin would be a better marker than glycated haemoglobin. However, glycated albumin is also affected by obesity and albumin, and it is desirable to make a comprehensive judgment with glycated haemoglobin, random plasma glucose and other glycaemic index.


Subject(s)
Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/complications , Glycated Hemoglobin/chemistry , Serum Albumin/chemistry , Adult , Female , Glycation End Products, Advanced , Humans , Infant, Newborn , Pregnancy , Pregnancy Complications , Prospective Studies , Reference Standards , Glycated Serum Albumin
3.
J Reprod Immunol ; 114: 65-74, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26282090

ABSTRACT

In oocyte donation (OD) pregnancies, a fetus is a complete allograft to the maternal host and OD pregnancies are an independent risk factor for preeclampsia. Immunocompetent cells contribute to spiral artery remodeling and the failure of this process could contribute to the pathophysiology of preeclampsia. Recent data have shown that impaired autophagy of extravillous trophoblasts (EVT) may induce poor vascular remodeling in preeclampsia. We have studied the distribution of T cells, NK cells and macrophages in the decidua basalis of 14 normotensive OD pregnancies, 5 preeclamptic OD cases, 16 normotensive pregnancy cases, and 13 preeclamptic cases in natural pregnancy or autologous oocyte IVF-ET (NP/IVF). The populations of decidual CD3(+)T cells, CD8(+)T cells, CD4(+)T cells, Foxp3(+)Treg cells, CD56(+)NK cells, and CD68(+) macrophages in preeclampsia were significantly smaller than those in normal pregnancy in NP/IVF. Those frequencies in normotensive OD pregnancies or preeclamptic cases in OD pregnancies were similar to those in preeclamptic cases in NP/IVF. Impaired vascular remodeling was observed in OD pregnancies, regardless of the presence or absence of preeclampsia. The expression of p62, an impaired autophagy marker in EVT of normotensive or preeclamptic OD pregnancies, was significantly higher than that in normal pregnancies in NP/IVF. Immunological change in the decidua basalis and impairment of autophagy in EVT may induce impairment of spiral artery remodeling in OD pregnancies.


Subject(s)
Decidua/immunology , Killer Cells, Natural/immunology , Monocytes/immunology , Oocyte Donation , Pre-Eclampsia/immunology , T-Lymphocytes/immunology , Vascular Remodeling/immunology , Adult , Decidua/pathology , Female , Humans , Killer Cells, Natural/pathology , Middle Aged , Monocytes/pathology , Pre-Eclampsia/pathology , Pregnancy , T-Lymphocytes/pathology
5.
J Obstet Gynaecol Res ; 40(1): 53-61, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23937716

ABSTRACT

AIM: To examine the relationship between preterm birth and socioeconomic factors, past history, cervical length, cervical interleukin-8, bacterial vaginosis, underlying diseases, use of medication, employment status, sex of the fetus and multiple pregnancy. METHODS: In a multicenter, prospective, observational study, 1810 Japanese women registering their future delivery were enrolled at 8⁺° to 12⁺6 weeks of gestation. Data on cervical length and delivery were obtained from 1365 pregnant women. Multivariate logistic regression analysis was performed. RESULTS: Short cervical length, steroid use, multiple pregnancy and male fetus were risk factors for preterm birth before 34 weeks of gestation. Multiple pregnancy, low educational level, short cervical length and part-timer were risk factors for preterm birth before 37 weeks of gestation. CONCLUSION: Multiple pregnancy and cervical shortening at 20-24 weeks of gestation was a stronger risk factor for preterm birth. Any pregnant woman being part-time employee or low educational level, having a male fetus and requiring steroid treatment should be watched for the development of preterm birth.


Subject(s)
Cervix Uteri/pathology , Pregnancy, Multiple , Premature Birth/epidemiology , Steroids/adverse effects , Women, Working , Adult , Cervical Length Measurement , Cervix Uteri/diagnostic imaging , Educational Status , Female , Humans , Incidence , Infant, Newborn , Japan/epidemiology , Male , Organ Size , Pregnancy , Pregnancy Outcome , Premature Birth/chemically induced , Premature Birth/etiology , Premature Birth/pathology , Prevalence , Risk Factors , Sex Characteristics , Socioeconomic Factors
6.
J Obstet Gynaecol Res ; 39(1): 160-5, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22765887

ABSTRACT

AIM: We have examined the risk factors and management processes of the persistent occiput posterior (pOP) position by analyzing medical records from our hospital. MATERIAL AND METHODS: Medical records and delivery notes from January 2007 to December 2009 were reviewed and 103 patients were identified as having the pOP position during active labor. A total of 1054 patients who had occiput anterior (OA) deliveries were used as control. RESULTS: There was no significant difference in population background between the pOP and control groups. Fifty-eight (56%) cases of pOP were identified before the birth of the fetal head whereas 45 were found to be in pOP at the birth. Among these cases identified as pOP before the birth, 30 (52%) patients underwent an attempt to rotate pOP to OA manually. A total of 14 (47%) attempts were successful and delivered OA vaginally. Of 16 cases whose attempts failed, five (31%) had cesarean delivery and 11 had vaginal OP delivery. The overall cesarean rate in this group was 16.7%. Twenty-eight patients who did not have any corrective intervention had a significantly higher rate of cesarean section (60.7%, P<0.001 by χ(2) analysis). The advanced head station and the wider dilatation resulted in a successful manual rotation. CONCLUSIONS: Attempts to correct pOP by manual rotation have better results when the head is in the mid-pelvis. Also, posture change reduces cesarean section rate. The current data suggest attempts to correct pOP to OA reduce cesarean section rate.


Subject(s)
Delivery, Obstetric , Head , Labor Presentation , Cesarean Section , Female , Humans , Pregnancy , Retrospective Studies , Risk Factors
7.
J Obstet Gynaecol Res ; 38(3): 597-600, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22353374

ABSTRACT

In general, primary amenorrhea is caused by gonadal dysgenesis, anomalies of internal or external genitalia with or without chromosomal anomalies, and sometimes by hormonal abnormalities that affect the hypothalamus, pituitary, ovaries, adrenals or thyroid, or by chronic or metabolic diseases. We report a rare case of a juvenile granulosa-cell tumor of the ovary that caused primary amenorrhea in a 16-year-old girl. Her hormonal profiles before the operation were characterized by an extremely low level of follicle-stimulating hormone (FSH), a relatively low level of estradiol and a high level of inhibin B. The patient had menarche after the removal of the tumor. Her elevated serum FSH after the operation was the result of a decreased serum level of inhibin that had been produced by the tumor. The present case highlights that a granulosa-cell tumor, known as an inhibin-secreting tumor, should be considered when treating primary amenorrheic girls.


Subject(s)
Amenorrhea/etiology , Granulosa Cell Tumor/diagnosis , Adolescent , Female , Granulosa Cell Tumor/complications , Humans
8.
Int J Hematol ; 95(1): 57-63, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22160834

ABSTRACT

Only a limited number of case reports documenting the off-label use of recombinant factor VIIa (rFVIIa) in Japanese patients with postpartum haemorrhage (PPH) have been published. Data on Japanese cases with severe PPH in which rFVIIa was administered were collected. Data of obstetric haemorrhage patients treated with rFVIIa between 2005 and 2010 were retrospectively collected throughout Japan. The data included patients' background information, blood product requirements, dose/timing of rFVIIa, and adverse effects. Treating clinicians subjectively assessed the effect of rFVIIa on bleeding at each administration using four categories: "Stopped", "Decreased", "Unchanged", and "Increased". A total of 25 women received rFVIIa for the treatment of obstetric haemorrhage in 18 institutions. After the final administration, bleeding was "stopped" in 16 patients (64%), "decreased" in eight patients (32%), and "unchanged" in one patient (4%). A significant reduction in blood product requirement was observed following the first rFVIIa administration. Hysterectomy was required in two patients (15.4%) after rFVIIa administration. Four asymptomatic thrombotic events were reported in three patients. These results suggest that rFVIIa can be a beneficial therapeutic option that can reduce blood loss and prevent hysterectomy in Japanese patients with massive obstetric bleeding.


Subject(s)
Coagulants/therapeutic use , Factor VIIa/therapeutic use , Postpartum Hemorrhage/drug therapy , Adult , Female , Humans , Japan , Off-Label Use , Postpartum Hemorrhage/physiopathology , Pregnancy , Recombinant Proteins/therapeutic use , Retrospective Studies , Severity of Illness Index , Young Adult
9.
Endocr J ; 59(2): 145-51, 2012.
Article in English | MEDLINE | ID: mdl-22166921

ABSTRACT

Glycemic control is an important issue in gestational diabetes mellitus (GDM) and in diabetic pregnant women. We determined the reference intervals of glycated albumin (GA) and hemoglobin A1c (HbA1c) as glycemic control markers in healthy Japanese pregnant women and analyzed their time courses and factors that influence these variables during pregnancy. 676 women were screened for the present study. After the exclusion of non-pregnant and puerperal women, 574 women were studied to determine the reference intervals. HbA1c, GA, casual plasma glucose, urinary glucose, urinary protein, and body mass index (BMI) (non-pregnancy) were measured. HbA1c levels significantly decreased in the second trimester of pregnancy and increased in the third trimester, while GA levels significantly decreased towards the third trimester. Casual plasma glucose levels decreased in the first trimester and subsequently remained constant. The reference intervals of GA and HbA1c in the healthy pregnant women were 11.5-15.7% and 4.5-5.7%, respectively. GA levels were lower (p<0.01) and HbA1c levels were higher (p<0.05) in pregnant women with proteinuria. In the obese group, GA levels were lower (p<0.01) than those of the control group (18.5≤ BMI <25kg/m²), and HbA1c levels were higher (p<0.01) than those of the control group. On the basis of the results of this multicenter study, the reference intervals of GA and HbA1c in healthy Japanese pregnant women were determined. Strict glycemic control is essential to reduce perinatal complications. GA appears to be a useful marker for pregnant women, since it can be measured easily and changes rapidly and markedly.


Subject(s)
Glycated Hemoglobin/analysis , Glycosuria/blood , Obesity/blood , Pregnancy Complications/blood , Proteinuria/blood , Serum Albumin/analysis , Biomarkers/blood , Biomarkers/urine , Blood Glucose/analysis , Body Mass Index , Cross-Sectional Studies , Diabetes, Gestational/blood , Diabetes, Gestational/urine , Female , Glycation End Products, Advanced , Glycosuria/urine , Humans , Japan , Obesity/urine , Pregnancy , Pregnancy Complications/urine , Pregnancy Trimesters , Proteinuria/urine , Glycated Serum Albumin
10.
Ind Health ; 49(2): 228-34, 2011.
Article in English | MEDLINE | ID: mdl-21173526

ABSTRACT

Women's employment in Japan has increased substantially in recent decades, however little large scale research has been done on the impact of various types of working conditions on women's health. The aim of this study was to assess the menstrual cycle and menstrual pain problems of female workers and to investigate the factors that relate to them. The questionnaire was distributed to 8,150 women and 2,166 responded (26.6%). An anonymous self-administered questionnaire was used to get information about demographics, menstrual cycle status, the degree of menstrual pain, and employment and environmental factors. Irregular cycle menstruation was experienced in 17.1% of responded workers. We discovered the relationship between irregular menstrual cycles and stress, smell of cigarettes, age and smoking habits. Some degree of menstrual pain was experienced in 77.6% of responded workers. This study showed the relationship between menstrual pain and stress, high temperature and humidity, age, BMI, and number of births. In conclusion, we found that stress is thought to be an important factor related with menstrual cycle irregularities and menstrual pain among Japanese female workers.


Subject(s)
Dysmenorrhea/epidemiology , Menstrual Cycle , Women, Working/statistics & numerical data , Adolescent , Adult , Age Factors , Body Mass Index , Dysmenorrhea/complications , Dysmenorrhea/psychology , Environment , Female , Health Behavior , Hot Temperature/adverse effects , Humans , Japan/epidemiology , Middle Aged , Occupations , Parity , Risk Factors , Socioeconomic Factors , Stress, Psychological/complications , Women, Working/psychology , Young Adult
11.
Hypertens Pregnancy ; 30(4): 457-64, 2011.
Article in English | MEDLINE | ID: mdl-21174584

ABSTRACT

OBJECTIVES: We studied the clinical management and prognosis of pregnant women with a history of abruption, as well as the associated risk factors. METHODS: We reviewed the cases of 23 patients with a history of abruption and 66 patients with abruption. RESULTS: The recurrence rate of abruption was 4.3%. Intentional care prolonged gestational age in most patients. Although the incidence of abruption was low (0.44%), the consequences could be perinatal death and maternal disseminated vascular coagulation (DIC). CONCLUSION: To prevent abruption recurrence, careful monitoring during hospitalization is important. Both clinical findings and transabdominal echography are useful in diagnosing abruption.


Subject(s)
Abruptio Placentae/epidemiology , Abruptio Placentae/prevention & control , Prenatal Diagnosis , Abruptio Placentae/diagnosis , Adult , Female , Gestational Age , Humans , Japan/epidemiology , Pregnancy , Pregnancy Outcome , Prenatal Care , Recurrence , Retrospective Studies , Risk Factors
12.
Biol Blood Marrow Transplant ; 15(4): 439-46, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19285631

ABSTRACT

Incidence and characteristics of early bacterial infection within 100 days after unrelated cord blood transplantation (UCBT) were assessed for 664 pediatric and 1208 adult recipients in Japan. Cumulative incidence of early bacterial infection at day 100 post-UCBT was 11% (95% confidence interval [CI], 8%-13%) for children and 21% (CI, 19%-24%) for adults (P < .0001). Early bacterial infection in adults had a significant impact on mortality (hazard ratio [HR] = 2.1, CI, 1.7-2.6; P < .0001), although no significant risk factors were identified. Multivariate analysis identified older age group (6-10, and 11-15 years versus 0-5 years of age) at transplant (HR = 2.0 and 2.7, CI, 1.1-3.5 and 1.4-4.9; P = .020 and .002, respectively) as an independent risk factor of early bacterial infection for children. Early bacterial infection in children did not have a significant impact on mortality when adjusted. Of 315 bacteremia, 74% were caused by Gram-positive microorganisms. Pneumonia occurred in 39 patients including 13 cases of Stenotrophomonas maltophilia pneumonia. Early bacterial infection had a negative effect on survival for adults and the median day of development was 10 days after transplant, suggesting that the prevention of bacterial infection in the very early post-UCBT phase is important.


Subject(s)
Cord Blood Stem Cell Transplantation , Gram-Negative Bacterial Infections/mortality , Gram-Positive Bacterial Infections/mortality , Pneumonia, Bacterial/mortality , Adolescent , Adult , Age Factors , Child , Child, Preschool , Disease-Free Survival , Female , Hematologic Neoplasms/microbiology , Hematologic Neoplasms/mortality , Hematologic Neoplasms/therapy , Humans , Incidence , Infant , Infant, Newborn , Male , Metabolic Diseases/microbiology , Metabolic Diseases/mortality , Metabolic Diseases/therapy , Middle Aged , Retrospective Studies , Risk Factors , Stenotrophomonas maltophilia , Survival Rate , Transplantation, Homologous
13.
Circ J ; 72(5): 753-6, 2008 May.
Article in English | MEDLINE | ID: mdl-18441455

ABSTRACT

BACKGROUND: Although pulmonary thromboembolism (PTE) has been considered relatively uncommon in Japan, its incidence has been on the increase in recent years. METHODS AND RESULTS: To verify the incidence of PTE in Japan, PTE cases of obstetrics and gynecology were investigated among 102 facilities throughout Japan between 1991 and 2000. A total of 254 cases were enrolled, showing a 6.5-fold increase over the past 10 years. PTE occurred in 0.02% of total births; 0.003% after vaginal deliveries and 0.06% after cesarean births (C/S), of which 14.5% resulting in fatality. The mortality rate was 2.5 per 100,000 deliveries. The incidences among gynecological cases were 0.08% of total operations; 0.03% in benign diseases and 0.42% in malignant diseases of which 13.5% resulting in fatality. The mortality rate was 10.8 per 100,000 operations. The risk was 22 times higher in C/S compared with vaginal deliveries, 16 times higher in malignant diseases compared with benign diseases. CONCLUSIONS: As our present survey has shown, PTE has been on the rise in Japan in recent years. C/S and malignant diseases are strong risk factors in obstetrics and gynecology.


Subject(s)
Gynecology , Obstetrics , Pregnancy Complications, Cardiovascular/epidemiology , Pulmonary Embolism/epidemiology , Cesarean Section/statistics & numerical data , Female , Humans , Incidence , Japan/epidemiology , Ovarian Neoplasms/epidemiology , Pregnancy , Risk Factors
14.
J Pediatr Surg ; 43(2): 358-61, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18280290

ABSTRACT

BACKGROUND AND PURPOSE: The association of growth retardation and hypospadias is well established. Fetal testosterone secretion is under the influence of placental human chorionic gonadotropin during first 14 weeks of gestation. We hypothesized that placental insufficiency may disrupt the supply of nutrients and human chorionic gonadotropin to the fetus leading to both growth retardation and hypospadias. To validate this hypothesis, we analyzed extremely low-birth-weight male infants with or without hypospadias for fetal growth parameters. MATERIALS AND METHODS: One hundred four male newborn infants with birth body weight of less than 1500 g admitted to a neonatal intensive care unit over a 4-year period were retrospectively reviewed, recording the presence and type of hypospadias, fetal growth parameters, infant growth parameters at birth, placental weight, placental histopathology, cord information, and maternal morbidity. These data of patients with hypospadias were compared with those of controls. RESULTS: Of the 104 extremely to very low-birth-weight male infants, 16 (15.3%) had hypospadias, and 10 (62.5%) of those had severe proximal hypospadias. Sixty-two controls who did not have hypospadias and whose body weight was less than 1500 g were identified. The incidence of hypospadias in full-term male birth in the hospital was 12 (0.30%) in 3959 births. Birth body weight and their SD for gestational age were lower in patients with hypospadias compared with those for controls (824 +/- 160 vs 1255 +/- 145 g). Placenta-to-fetal ratio (0.323 +/- 0.07 vs 0.229 +/- 0.03) and gestational age were significantly higher in the patients with hypospadias. Histopathologic study of the maternal placenta obtained from the patients with hypospadias revealed pronounced degenerative changes, infarction, and calcification, whereas these abnormalities were rare in controls. CONCLUSIONS: The significant association between the occurrence of hypospadias and early growth retardation with higher placenta-to-fetal ratio and placental abnormalities suggest that placental dysfunction in early gestation may play an important role in the development of hypospadias.


Subject(s)
Fetal Growth Retardation/diagnostic imaging , Hypospadias/epidemiology , Infant, Very Low Birth Weight , Placental Insufficiency/diagnostic imaging , Case-Control Studies , Female , Fetal Growth Retardation/physiopathology , Follow-Up Studies , Gestational Age , Humans , Hypospadias/etiology , Hypospadias/surgery , Infant, Newborn , Male , Placental Insufficiency/physiopathology , Pregnancy , Prevalence , Probability , Reference Values , Retrospective Studies , Risk Assessment , Treatment Outcome , Ultrasonography, Prenatal , Urologic Surgical Procedures, Male/methods
15.
Semin Thromb Hemost ; 31(3): 253-60, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16052393

ABSTRACT

Cesarean section has been identified as a major risk factor for thromboembolism, and additional risk factors place some women at a much higher risk during puerperium. Recently, low molecular weight heparins (LMWHs) have been used for thromboembolism prophylaxis after cesarean section. We investigated the effect of risk factors of thromboembolism on plasma coagulation markers when the LMWH dalteparin was used following cesarean section. Twenty-four women with risk factors other than cesarean section (high-risk group) and 13 without any other risk factors (low-risk group) received dalteparin starting immediately after cesarean section until the patients were mobilized. Sixteen women without any other risk factors served as controls (control group). Activated partial thromboplastin times, thrombin-antithrombin complex, alpha (2)-plasmin inhibitor-plasmin complex, and activated factor X levels were not different between the high-risk and the low-risk groups. However, fibrinogen/fibrin degradation products D-dimer levels were higher in the high-risk group than in the low-risk and control groups on days 3 and 7 after cesarean section. These findings suggest that the D-dimer levels may be elevated by some risk factors and that postoperative D-dimer determinations may be useful in assessing the risk of thromboembolism during LMWH treatment after cesarean section.


Subject(s)
Blood Coagulation/drug effects , Cesarean Section/adverse effects , Heparin, Low-Molecular-Weight/pharmacology , Postoperative Complications/prevention & control , Adult , Biomarkers/blood , Dalteparin/administration & dosage , Dalteparin/pharmacology , Female , Fibrin Fibrinogen Degradation Products/analysis , Heparin, Low-Molecular-Weight/administration & dosage , Humans , Postoperative Complications/drug therapy , Pregnancy , Premedication , Risk Assessment , Risk Factors , Thromboembolism
16.
Endocr Relat Cancer ; 12(1): 101-7, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15788642

ABSTRACT

Androgens have been proposed to be actively produced in situ in human prostate cancer. These locally produced androgens have also been considered to play important roles in the pathogenesis and development of prostate cancer. Therefore, it is important to examine the status of this in situ androgen metabolism and/or synthesis in detail in order to improve the clinical response to hormonal therapy in patients diagnosed with prostate cancer. Several studies have previously demonstrated the expression of androgen-producing enzymes such as 5alpha-reductase types 1 and 2, and 17beta-hydroxysteroid dehydrogenase type 5 (17beta-HSD5), in human prostate carcinoma cells. However, their biological significance has remained largely unknown. In this study, we evaluated the immunoreactivities of these steroidogenic enzymes in human prostate cancer obtained from surgery (n = 70), and correlated the findings with clinicopathological features of the patients. 17Beta-HSD5 immunoreactivity was detected in 54 cases (77%), 5alpha-reductase type 1 in 51 cases (73%) and 5alpha-reductase type 2 in 39 cases (56%). 5Alpha-reductase type 2 immunoreactivity was significantly correlated with that of androgen receptor (AR), and 17beta-HSD5 positive cases were significantly associated with clinical stage (TNM stage pT3 vs pT2). These data all suggest that androgen-producing enzymes, such as 5alpha-reductase type 1 and type 2, and 17beta-HSD5 are expressed in a majority of prostate cancers, and are involved in the local production and actions of androgens in prostate cancers.


Subject(s)
17-Hydroxysteroid Dehydrogenases/metabolism , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Androgens/metabolism , Prostatic Neoplasms/enzymology , Receptors, Androgen/metabolism , Aged , Humans , Immunoenzyme Techniques , Male , Middle Aged , Prostatic Neoplasms/pathology
17.
Ophthalmologica ; 218(5): 344-9, 2004.
Article in English | MEDLINE | ID: mdl-15334016

ABSTRACT

Experimentally induced ischemia of the endothelial cells surrounding the aqueous drainage sites led to a rise in intraocular pressure (IOP) in monkey and pigeon eyes. Clinical conditions associated with a rise in IOP in human eyes, e.g. peripheral retinal detachments, subluxated lenses, and occlusion of the internal carotid artery, can result in ischemia of the endothelial cells lining Schlemm's canal. These findings led to the hypothesis that ischemia of the endothelial cells of Schlemm's canal induces hypertension in human eyes. Thus, the ischemia hypothesis should be considered in discussions of the etiology of age-related open-angle glaucoma.


Subject(s)
Endothelium, Vascular/pathology , Intraocular Pressure , Ischemia/complications , Ocular Hypertension/etiology , Trabecular Meshwork/blood supply , Animals , Glaucoma/congenital , Glaucoma, Angle-Closure/etiology , Glaucoma, Open-Angle/etiology , Humans
18.
J Clin Endocrinol Metab ; 89(4): 1897-903, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15070962

ABSTRACT

Urocortin III (Ucn III)/stresscopin (SCP) is a novel peptide of the corticotropin-releasing factor (CRF) family and is a specific ligand for the CRF type 2 receptor. We wished to clarify whether Ucn III/SCP is expressed in the human heart and kidney. Immunoreactive Ucn III was detected by RIA in the human heart (0.74-1.15 pmol/g wet weight, mean +/- SEM; n = 4) and kidney (1.21 +/- 0.30 pmol/g wet weight), which were obtained at autopsy. These levels were comparable to the levels in pituitary (2.72 +/- 0.13 pmol/g wet weight; n = 3) and brain tissues ( approximately 1-2 pmol/g wet weight). Furthermore, immunoreactive Ucn III was present in human plasma (51.8 +/- 16.0 pmol/liter; n = 5) and urine (266 +/- 20 pmol/liter; n = 5) obtained from healthy subjects. Reverse-phase HPLC showed a broad peak of immunoreactive Ucn III eluting in the position of synthetic Ucn III in the heart, kidney, and hypothalamus. Material eluting in the position of SCP was also found in the HPLC analysis of these tissue extracts. Immunocytochemistry showed positive staining of Ucn III in the myocardium and the renal tubules, particularly distal tubules. RT-PCR showed expression of Ucn III mRNA in the brain, pituitary, heart, and kidney. The present study has shown expression of Ucn III/SCP in the human heart and kidney as well as brain and pituitary tissues and its presence in plasma and urine. Ucn III/SCP may therefore regulate the cardiac and renal function as a local factor and a circulating hormone.


Subject(s)
Corticotropin-Releasing Hormone/metabolism , Kidney/metabolism , Myocardium/metabolism , Adult , Aged , Brain/metabolism , Case-Control Studies , Chromatography, High Pressure Liquid , Corticotropin-Releasing Hormone/blood , Corticotropin-Releasing Hormone/genetics , Corticotropin-Releasing Hormone/urine , Female , Humans , Immunohistochemistry , Male , Middle Aged , Pituitary Gland/metabolism , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Thalamus/metabolism , Tissue Distribution , Urocortins
19.
Mol Cell Endocrinol ; 205(1-2): 43-50, 2003 Jul 31.
Article in English | MEDLINE | ID: mdl-12890566

ABSTRACT

Orexin-A is a neuropeptide present in the brain and is known to regulate feeding and sleeping. In this study, we examined the systemic distribution of orexin-A in human tissues. Immunoreactivity for orexin-A was detected in ganglion cells of the thoracic sympathetic trunk, myenteric plexuses and endocrine cells of the gastrointestinal tract, islet cells of the pancreas and syncytiotrophoblasts and decidual cells of the placenta. In the gastrointestinal tract, orexin-A immunoreactivity was detected in the myenteric plexuses from 26 gestational weeks to birth. In double immunostaining in the pancreas, a great majority of insulin-positive cells was simultaneously positive for orexin-A. mRNA expression for prepro-orexin was also detected in the kidney, adrenal gland, pancreas, placenta, stomach, ileum, colon and colorectal epithelial cells. These results suggest the production of orexin-A in various human peripheral tissues and orexin-A may also play important roles in some peripheral organs.


Subject(s)
Carrier Proteins/metabolism , Intracellular Signaling Peptides and Proteins , Neuropeptides/metabolism , Adolescent , Adult , Carrier Proteins/chemistry , Carrier Proteins/genetics , Child , Child, Preschool , Female , Gene Expression , Humans , Immunohistochemistry , Infant , Infant, Newborn , Neuropeptides/chemistry , Neuropeptides/genetics , Orexins , Pregnancy , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Tissue Distribution
20.
Int J Clin Oncol ; 8(1): 60-4, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12601546

ABSTRACT

A case of stage IVB adenoacanthoma of the uterine corpus is described. The patient was admitted with a large amount of atypical genital bleeding. Computed tomography and magnetic resonance imaging revealed a large tumor accompanied by lymph node involvement in the left inguinal, multiple pelvic, and paraaortic regions. She was diagnosed as having stage IVB endometrial adenoacanthoma. Neoadjuvant chemotherapy with carboplatin (CBDCA) and 5-fluorouracil (5-FU) was performed, followed by radiotherapy. The tumor responded very well, but still remained in Douglas' pouch after treatment. The patient therefore underwent a simple hysterectomy, pelvic and paraaortic lymphadenectomy, and partial rectal resection. Histopathologically, viable cancer cells were observed only in the fundus of the uterus. The patient is alive with no evidence of recurrence 4 years after the initiation of chemoradiotherapy.


Subject(s)
Adenocarcinoma/therapy , Endometrial Neoplasms/therapy , Salvage Therapy , Uterine Neoplasms/therapy , Uterus/pathology , Adenocarcinoma/diagnosis , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carboplatin/administration & dosage , Endometrial Neoplasms/diagnosis , Female , Fluorouracil/administration & dosage , Humans , Magnetic Resonance Imaging , Metaplasia/diagnosis , Metaplasia/therapy , Middle Aged , Neoadjuvant Therapy , Neoplasm Staging , Radiotherapy, Adjuvant , Tomography, X-Ray Computed , Uterine Neoplasms/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...